Insider · CIK 0001954793
Ronald Len Zimmerly Jr.
Files at MBCN (MIDDLEFIELD BANC CORP). First filing -, latest -.
In brief
Ronald Len Zimmerly Jr. files SEC Form 4 as CEO and director at MBCN (MIDDLEFIELD BANC CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ronald Len Zimmerly Jr. has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | MBCN MIDDLEFIELD BANC CORP | DDisposition to issuer Common Stockindirect: Held in IRA | -8,786 | - | - | 0 | Mar 2, 2026 |
| Mar 2, 2026 | MBCN MIDDLEFIELD BANC CORP | DDisposition to issuer Common Stock | -84,689 | - | - | 0 | Mar 2, 2026 |
| Feb 23, 2026 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Common Stock | +4,520 | $35.18 | $159k | 55,254 | Feb 25, 2026 |
| Feb 23, 2026 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Common Stock | +4,576 | $35.18 | $161k | 59,830 | Feb 25, 2026 |
| Feb 23, 2026 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Common Stock | +19,500 | $35.18 | $686k | 79,330 | Feb 25, 2026 |
| Feb 23, 2026 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Common Stock | +30,030 | $35.18 | $1.1M | 109,360 | Feb 25, 2026 |
| Feb 23, 2026 | MBCN MIDDLEFIELD BANC CORP | FTax withholding Common Stock | -24,671 | $35.18 | $868k | 84,689 | Feb 25, 2026 |
| Jan 14, 2026 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Common Stock | +2,288 | $34.50 | $79k | 51,492 | Jan 16, 2026 |
| Jan 14, 2026 | MBCN MIDDLEFIELD BANC CORP | FTax withholding Common Stock | -758 | $34.50 | $26k | 50,734 | Jan 16, 2026 |
| Dec 17, 2025 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Common Stock | +4,653 | $37.00 | $172k | 43,169 | Dec 18, 2025 |
| Dec 17, 2025 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Common Stock | +10,161 | $37.00 | $376k | 53,330 | Dec 18, 2025 |
| Dec 17, 2025 | MBCN MIDDLEFIELD BANC CORP | FTax withholding Common Stock | -4,126 | $37.00 | $153k | 49,204 | Dec 18, 2025 |
| Dec 1, 2025 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Common Stock | +3,788 | $34.82 | $132k | 39,628 | Dec 3, 2025 |
| Dec 1, 2025 | MBCN MIDDLEFIELD BANC CORP | FTax withholding Common Stock | -1,112 | $34.82 | $39k | 38,516 | Dec 3, 2025 |
| Aug 6, 2025 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Common Stock | +2,260 | $27.11 | $61k | 36,503 | Aug 7, 2025 |
| Aug 6, 2025 | MBCN MIDDLEFIELD BANC CORP | FTax withholding Common Stock | -663 | $27.11 | $18k | 35,840 | Aug 7, 2025 |
| Jan 14, 2025 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Conditional Stock Awardderivative | +6,864 | - | - | 6,864 | Aug 7, 2025 |
| Dec 1, 2024 | MBCN MIDDLEFIELD BANC CORP | AGrant or award Common Stock | +3,788 | $30.98 | $117k | 35,077 | Dec 3, 2024 |
| Dec 1, 2024 | MBCN MIDDLEFIELD BANC CORP | FTax withholding Common Stock | -1,112 | $30.98 | $34k | 33,965 | Dec 3, 2024 |
Questions about Ronald Len Zimmerly Jr.
Answered from the filings on this page, as of the latest one.
Is Ronald Len Zimmerly Jr. buying or selling?
Ronald Len Zimmerly Jr. has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ronald Len Zimmerly Jr.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronald Len Zimmerly Jr. has 0.
Where does Ronald Len Zimmerly Jr. file Form 4?
Ronald Len Zimmerly Jr. has filed Form 4 at MBCN (MIDDLEFIELD BANC CORP) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.